Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy

Panic disorder (PD) is a prevalent type of anxiety disorder. Previous studies have reported abnormal brain activity in the fear network of patients with PD. Nonetheless, it remains uncertain whether pharmacotherapy can effectively normalize these abnormalities. This longitudinal resting-state functi...

Full description

Bibliographic Details
Main Authors: Haohao Yan, Yiding Han, Xiaoxiao Shan, Huabing Li, Feng Liu, Ping Li, Jingping Zhao, Wenbin Guo
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/9/2420
_version_ 1827727087430008832
author Haohao Yan
Yiding Han
Xiaoxiao Shan
Huabing Li
Feng Liu
Ping Li
Jingping Zhao
Wenbin Guo
author_facet Haohao Yan
Yiding Han
Xiaoxiao Shan
Huabing Li
Feng Liu
Ping Li
Jingping Zhao
Wenbin Guo
author_sort Haohao Yan
collection DOAJ
description Panic disorder (PD) is a prevalent type of anxiety disorder. Previous studies have reported abnormal brain activity in the fear network of patients with PD. Nonetheless, it remains uncertain whether pharmacotherapy can effectively normalize these abnormalities. This longitudinal resting-state functional magnetic resonance imaging study aimed to investigate the spontaneous neural activity in patients with PD and its changes after pharmacotherapy, with a focus on determining whether it could predict treatment response. The study included 54 drug-naive patients with PD and 54 healthy controls (HCs). Spontaneous neural activity was measured using regional homogeneity (ReHo). Additionally, support vector regression (SVR) was employed to predict treatment response from ReHo. At baseline, PD patients had aberrant ReHo in the fear network compared to HCs. After 4 weeks of paroxetine treatment (20 mg/day), a significant increase in ReHo was observed in the left fusiform gyrus, which had shown reduced ReHo before treatment. The SVR analysis showed significantly positive correlations (<i>p</i> < 0.0001) between the predicted and actual reduction rates of the severity of anxiety and depressive symptoms. Here, we show patients with PD had abnormal spontaneous neural activities in the fear networks. Furthermore, these abnormal spontaneous neural activities can be partially normalized by pharmacotherapy and serve as candidate predictors of treatment response. Gaining insight into the trajectories of brain activity normalization following treatment holds the potential to provide vital insights for managing PD.
first_indexed 2024-03-10T23:00:29Z
format Article
id doaj.art-979da9fafe7546dfbfedf68db783e649
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T23:00:29Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-979da9fafe7546dfbfedf68db783e6492023-11-19T09:41:04ZengMDPI AGBiomedicines2227-90592023-08-01119242010.3390/biomedicines11092420Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by PharmacotherapyHaohao Yan0Yiding Han1Xiaoxiao Shan2Huabing Li3Feng Liu4Ping Li5Jingping Zhao6Wenbin Guo7Department of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha 410011, ChinaDepartment of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha 410011, ChinaDepartment of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha 410011, ChinaDepartment of Radiology, The Second Xiangya Hospital of Central South University, Changsha 410011, ChinaDepartment of Radiology, Tianjin Medical University General Hospital, Tianjin 300052, ChinaDepartment of Psychiatry, Qiqihar Medical University, Qiqihar 161006, ChinaDepartment of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha 410011, ChinaDepartment of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha 410011, ChinaPanic disorder (PD) is a prevalent type of anxiety disorder. Previous studies have reported abnormal brain activity in the fear network of patients with PD. Nonetheless, it remains uncertain whether pharmacotherapy can effectively normalize these abnormalities. This longitudinal resting-state functional magnetic resonance imaging study aimed to investigate the spontaneous neural activity in patients with PD and its changes after pharmacotherapy, with a focus on determining whether it could predict treatment response. The study included 54 drug-naive patients with PD and 54 healthy controls (HCs). Spontaneous neural activity was measured using regional homogeneity (ReHo). Additionally, support vector regression (SVR) was employed to predict treatment response from ReHo. At baseline, PD patients had aberrant ReHo in the fear network compared to HCs. After 4 weeks of paroxetine treatment (20 mg/day), a significant increase in ReHo was observed in the left fusiform gyrus, which had shown reduced ReHo before treatment. The SVR analysis showed significantly positive correlations (<i>p</i> < 0.0001) between the predicted and actual reduction rates of the severity of anxiety and depressive symptoms. Here, we show patients with PD had abnormal spontaneous neural activities in the fear networks. Furthermore, these abnormal spontaneous neural activities can be partially normalized by pharmacotherapy and serve as candidate predictors of treatment response. Gaining insight into the trajectories of brain activity normalization following treatment holds the potential to provide vital insights for managing PD.https://www.mdpi.com/2227-9059/11/9/2420panic disordermagnetic resonance imagingbrainbiomarkerfearanxiety
spellingShingle Haohao Yan
Yiding Han
Xiaoxiao Shan
Huabing Li
Feng Liu
Ping Li
Jingping Zhao
Wenbin Guo
Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy
Biomedicines
panic disorder
magnetic resonance imaging
brain
biomarker
fear
anxiety
title Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy
title_full Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy
title_fullStr Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy
title_full_unstemmed Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy
title_short Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy
title_sort breaking the fear barrier aberrant activity of fear networks as a prognostic biomarker in patients with panic disorder normalized by pharmacotherapy
topic panic disorder
magnetic resonance imaging
brain
biomarker
fear
anxiety
url https://www.mdpi.com/2227-9059/11/9/2420
work_keys_str_mv AT haohaoyan breakingthefearbarrieraberrantactivityoffearnetworksasaprognosticbiomarkerinpatientswithpanicdisordernormalizedbypharmacotherapy
AT yidinghan breakingthefearbarrieraberrantactivityoffearnetworksasaprognosticbiomarkerinpatientswithpanicdisordernormalizedbypharmacotherapy
AT xiaoxiaoshan breakingthefearbarrieraberrantactivityoffearnetworksasaprognosticbiomarkerinpatientswithpanicdisordernormalizedbypharmacotherapy
AT huabingli breakingthefearbarrieraberrantactivityoffearnetworksasaprognosticbiomarkerinpatientswithpanicdisordernormalizedbypharmacotherapy
AT fengliu breakingthefearbarrieraberrantactivityoffearnetworksasaprognosticbiomarkerinpatientswithpanicdisordernormalizedbypharmacotherapy
AT pingli breakingthefearbarrieraberrantactivityoffearnetworksasaprognosticbiomarkerinpatientswithpanicdisordernormalizedbypharmacotherapy
AT jingpingzhao breakingthefearbarrieraberrantactivityoffearnetworksasaprognosticbiomarkerinpatientswithpanicdisordernormalizedbypharmacotherapy
AT wenbinguo breakingthefearbarrieraberrantactivityoffearnetworksasaprognosticbiomarkerinpatientswithpanicdisordernormalizedbypharmacotherapy